Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

Affiliations

• ¹ Mount Sinai Heart, Icahn School of Medicine, Mount Sinai Health System, New York City, NY, USA. dlbhattmd@post.harvard.edu.
• ² Louisville Metabolic and Atherosclerosis Research Center, University of Louisville School of Medicine, Louisville, KY, USA.
• ³ Corporal Michael J. Crescenz VA Medical Center and Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
• ⁴ Family Medicine Clinic Science, Lampasas, TX, USA.
• ⁵ ZDROWIE Osteo-Medic, Bialystok, Poland.
• ⁶ Manassas Clinical Research Center, Manassas, VA, USA.
• ⁷ 89bio Inc., San Francisco, CA, USA.
• ⁸ Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.